In addition, in PDA cell lines ENO1 silencing impaired cell proliferation, enhanced apoptosis, modulated the actin reorganization from the membrane towards the cytoplasm and increased intracellular ROS, thus targeting ENO1 to modulate the redox homeostasis restored chemosensitivity to GEM [84,85]. The gene discussed is ENO1; the disease is Patent ductus arteriosus.